In light of recent concerns about extrapyramidal symptoms (EPS) as a potential side effect of aripiprazole, we conducted a meta-analysis to assess the incidence of EPS in children and adolescents. |
We found a mean incidence of 17.1 % (95 % confidence interval 0.128–0.223). |
This finding highlights the importance of considerate prescription of aripiprazole in youth. |